Key result
Adiposopathy interventions, including diet, exercise, and weight loss drugs, improve excessive fat-related metabolic diseases by favorably affecting fat function and nutrient metabolism.
Why the study?
How do diet, exercise, and weight loss drug therapies improve metabolic disease in overweight patients?
Population
Overweight patients with or at risk of excessive fat-related metabolic diseases (EFRMD)
Design
Review
Authors
Loading...
Fat dysfunction assessment may refine EFRMD risk beyond BMI; leaves open prospective validation for cardiovascular practice.
How do diet, exercise, and weight loss drug therapies improve metabolic disease in overweight patients?
Weight loss interventions and certain drugs improve metabolic diseases by targeting adiposopathy (fat dysfunction) rather than just reducing fat mass.
Bays et al. (2006) conducted a review in Excessive fat-related metabolic diseases (EFRMD) in overweight patients. Adiposopathy interventions (diet, exercise, and weight loss drugs) was evaluated. Adiposopathy interventions, including diet, exercise, and weight loss drugs, improve excessive fat-related metabolic diseases by favorably affecting fat function and nutrient metabolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: